Pamplona, Spain

Bruno David Lourenco Paiva

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bruno David Lourenco Paiva: Innovator in Immunotherapy

Introduction

Bruno David Lourenco Paiva is a notable inventor based in Pamplona, Spain. He has made significant contributions to the field of immunotherapy, particularly in the treatment of multiple myeloma. His innovative work has the potential to impact the lives of many patients suffering from this challenging disease.

Latest Patents

Bruno holds a patent for a bispecific antibody against BCMA and CD3, along with an immunological drug for combined use in treating multiple myeloma. This invention specifically targets human B cell maturation antigen (BCMA) and human CD3, offering a promising therapeutic approach for patients.

Career Highlights

Bruno is currently associated with Engmab Sàrl, where he continues to advance his research and development efforts. His work in the field of immunotherapy has garnered attention and respect from peers and industry professionals alike.

Collaborations

Bruno collaborates with talented individuals such as Minh Diem Vu and Klaus Strein, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Bruno David Lourenco Paiva is a pioneering inventor whose work in bispecific antibodies represents a significant advancement in the treatment of multiple myeloma. His contributions to immunotherapy are noteworthy and hold promise for future medical breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…